GeneDx Announced The First-of-its-kind Patient Access Program, Developed In Partnership With Leading Biopharma Companies, Which Aims To Increase Access To Exome Sequencing For Pediatric Epilepsy Patients
GeneDx Announced The First-of-its-kind Patient Access Program, Developed In Partnership With Leading Biopharma Companies, Which Aims To Increase Access To Exome Sequencing For Pediatric Epilepsy Patients
GeneDx宣佈與領先生物製藥公司合作開發首個獨特的患者接入計劃，旨在增加兒童癲癇患者對全外顯子測序的接觸。
GeneDx Announced The First-of-its-kind Patient Access Program, Developed In Partnership With Leading Biopharma Companies, Which Aims To Increase Access To Exome Sequencing For Pediatric Epilepsy Patients
GeneDx宣佈與領先的生物製藥公司合作開發了首個患者訪問計劃，旨在增加小兒癲癇患者接受外顯子測序的機會。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。